Using a large number of computers to screen TB drugs reduces the cost and time.
Academic rigour, journalistic flair
Articles on Tuberculosis (TB)
Displaying 101 - 120 of 179 articles
Despite the myth of consumption as an ethereal, wasting disease, the more prosaic truth is that the Brontës likely infected one another with tuberculosis.
We cannot end TB with century-old technologies and poor quality care. It is time to reinvent the way we are managing TB, and overcome our collective failures of the imagination.
Antibiotic resistance is a major and growing global health threat. These five recent examples show us how dangerous it can be.
The reason that nanoparticles hold such hope for TB treatment is that they can be carefully targeted.
The bill to provide universal health care in South Africa is not the silver bullet for the challenges in the health sector.
Treatment for drug-resistant TB remains problematic as the painful daily injectable patients receive for at least six months leaves more than 60% deaf.
Countries globally should adopt and adapt the World Health Organization’s new Essential Diagnostics List – as a key step in the management of all diseases.
Class action is a newish feature within South Africa’s legal landscape. Cases such as the silicosis matter are likely to influence many more.
The TB epidemic is out of control in Canada’s North. Eliminating the disease will require accurate data as well as government investment.
World TB Day will be observed March 24, with the good news that deaths from tuberculosis are declining. But a trend toward confining those with TB threatens to stall advances.
The current range of TB diagnostic tests have various limitations like the sputum smear which is outdated, clumsy and takes long to process.
We can’t eradicate TB without also addressing poverty.
On World TB Day 2018, eradicating TB finally looks like a goal that could be met — if political leaders can step up with cash and actions to match their political declarations.
A cure for many tropical diseases was discovered 30 years ago this month. The drug is donated by its manufacturer. Why are we still dealing with neglected tropical diseases?
Infectious diseases pose a continual threat to Canadians. Ensuring the population stays healthy requires increasing investment in our public health system.
India has a radical new plan to eliminate TB, backed by research and technological expertise. The country just needs strong financial and political commitment from government to implement it.
Tuberculosis has had a significant impact on the world, from influencing fashion trends to helping understand how the human body works.
The health care debate in the US has focused on a looming crisis, with millions possibly losing insurance coverage. In India, an immediate crisis looms with tuberculosis.
We’ve been told for a long time that we must take all of our antibiotics. But maybe we didn’t need so many to begin with. Here’s why.
Top contributors
-
Canada Research Chair of Epidemiology & Global Health, McGill University
-
Assistant Professor, Africa Health Research Institute (AHRI)
-
Head of the Centre of Excellence for Biomedical TB Research, University of the Witwatersrand
-
Faculty Member, Africa Health Research Institute; Associate professor, UCL
-
Associate Professor, Melbourne Health
-
Honorary Research Associate, Centre for Infectious Disease Epidemiology and Research, University of Cape Town
-
Associate Professor in Paediatrics and Child Health, University of Sydney
-
Extraordinary Senior Lecture in the Department of Global Health, Stellenbosch University
-
Associate Professor of Biomedical Engineering, University of Michigan
-
Regional Adviser, Immunisation, WHO Regional Office for Africa, Stellenbosch University
-
Infectious Diseases Physician and Senior Clinical Lecturer, Liverpool School of Tropical Medicine and Honorary Research Associate, University of Liverpool
-
Associate Professor, Pharmaceutical Sciences, University of the Western Cape
-
Faculty Member, Africa Health Research Institute; Wellcome Trust Senior Research Fellow, UCL
-
Associate Professor, SARChI Research Chair in Mycobactomics, Stellenbosch University
-
Head of the Division of Pulmonology, University of Cape Town
